Seerave Foundation https://validator.w3.org/feed/docs/rss2.html Rachel Herren Home Contact Seerave Ventures Meet the Microbiome & Cancer Working Group Launching the Seerave Global Oncobiome Atlas About Lisa Derosa Marthe Verhaert Sandrine Aspelagh Joseph Tintelnot Andrés Cubillos-Ruiz Raphaël Gayet Is Seerave a non-profit organisation? Would you consider leading an investment round? What stage of funding rounds does Seerave usually participate in? Johannes Björk Approach What is the Seerave’s policy on paying for grantees’ indirect costs (overheads)? Does Seerave jointly fund projects with other philanthropic entities? Where does Seerave’s funding come from? Ella Reich Daniel Woolf Selena Ahmed Franziska Deutschbein Seerave Retreat 2023 Seerave Retreat 2022 Cookies The Microbiome and Immuno-oncology in the Spotlight at ASCO 2025 Dispatch from Seerave Retreat 2024 Arielle Elkrief Stanford’s smart toilet analyzes urine and feces for signs of disease Microbial DNA in patient blood may be tell-tale sign of cancer Human microbiome-derived bacterial strains with antitumor activity Seerave invests in Florey Biosciences and takes aim at mitigating impacts of antibiotic use Seerave Announces Strategic Focus on Antibiotics and Cancer Immunotherapy The Melanoma & the Microbiome Workshop An engineered probiotic to manage the impacts of antibiotics Funder Impact Roundtable Benefits of Mediterranean diet in cancer treatment shown in PRIMM study Laura Bolte Privacy Policy Where does the name “Seerave” come from? How does Seerave select its grants and investments? Projects Abselion Florey Biosciences Arma Bioscience Biomesense Xsensio